Subject: [Homestead] U.S. gift of its manufacturing sector to China
Date: Sun, 29 Aug 2004 11:23:13 -0700
As it did for the U.S. when it was the manufacturing center of the
world, the manufacturig sector provides the income to China to become
the current world leader in the research activities that enhance and
sustain long-term military and economic power in all other sectors of
the economy, which are now being feverishly Sovietized by the U.S.
Brezhnev/Kruschev aka Bush..
The most grievous mistake the United States ever made was to throw away
it's manufacturing sector---the engine that produced a well-paid middle
class, the economic ladder for the poor to move up.
It occurred with lightning speed from 1990 to 2004. Two Presidents were
directly responsible, Clinton with sufficent intellect to realize what
he was doing, but without the will to stop it, and Bush with
insufficient intellect to realize the enormity of the damage he was
inflicting on the United States, but with a will perversely and
deliberately accellerating U.S. decline to reward his superbribers who
temporarily put and keep him in power. Once started and fueled by two
idiot Presidents, the process is irreversible.
Go East, young biotech
You might call it a new Silk Road. Just like Marco Polo back in the 13th
century, intrepid explorers from the West are once again beating a path
to the Far East in search of China's great riches. Only this time, the
profits won't come from jade or exotic spices; they're in the sciences.
For basic scientists in Europe and the United States, China has long
represented an enormous opportunity for collaboration. But a flurry of
recent news from agencies pushing stronger links with China, plus new
support from China's government, suggests interest is picking up pace.
For the biotech industry, this is good news.
In late July, for example, Germany's Helmholtz Association of National
Research Centres opened a Chinese officeonly its second overseas office
after Brusselswith the aim of boosting collaboration between researchers
at its 15 centers and their Chinese counterparts.
"Given the euphoric mood and the dynamism amongst the scientific
community in China, it seems only natural to open our first non-European
office in this country," says Helmholtz president Walter Kröll. Chinese
investigators already make up the third largest national group among
Helmholtz guest scientists.
Hong He, head of the Helmholtz Beijing office, explains what the Germans
hope to get from the deal; their ambitions are emblematic of those
seeking links with the Asian giant. "Joint ventures must always offer
identifiable benefits for both sides," he says. "On this basis, our
scientists at the Helmholtz Centres are researching highly complex
systems, together with their Chinese partners using large-scale
facilities and scientific infrastructures. Together they can achieve
their goals more swiftly and more efficiently."
Meanwhile, over in France, the Pasteur Institute in Paris is working
with the Chinese government on a project to open a research foundation
that will focus on public health needs and viral diseases. "The Chinese
have made it very clear that they hope this institute will have a
Diaspora effect," Michéle Boccoz, director of the international office
at the Pasteur Institute, told /The Scientist Daily News/ back in April.
And speaking of attracting a scientific Diaspora back to China, during
the 10th Annual Symposium of the Society of Chinese Bioscientists in
America (SCBA), held in Beijing in late July, scientists spoke of the
very bright future that biotechnology could have in the Chinese market
in the next few years. The Beijing meeting and another held in Shanghai
were the first meetings SCBA has ever held within China, says the
group's president, Mien-Chie Hung, of MD Anderson Cancer Center, Houston.
The visits left him smiling. "I am very impressed with the recent
progress of biological sciences in China," he says. "They are moving up
quickly. If you see the economic development in Shanghai, I think you
will agree that biotech development in China is advancing swiftly."
Venture capital, intellectual property, and entrepreneurship in life
sciences and biotechnology are booming, adds SCBA executive director
Joseph Li of Utah State University. Bioventure funding is readily
available, and the Chinese government is quite supportive, he says.
"Biotechnology development within China is going at an accelerating
pace," Li says. "The international biotech industry and companies are
eager to come to China to establish joint ventures." Those Silk Road
traders might have understood why.
*--Stephen Pincock *
[Homestead] U.S. gift of its manufacturing sector to China,
Tvoivozhd, 08/29/2004